Nexvel Biotech Introduces Medical Technology-Based Cosmetic Brand ‘Du2LAB’ at COSMOBEAUTY SEOUL 2026

Integrated Manufacturing, R&D, Export, and Distribution System Strengthens Confidence in Functional Cosmeceutical Brand

South Korean medical and bio company Nexvel Biotech is set to officially enter the beauty market through its cosmetic brand Du2LAB.

The brand will make its domestic debut at COSMOBEAUTY SEOUL 2026, drawing industry attention as a functional cosmetic brand developed with medical-device-based technology.

The global beauty industry is rapidly evolving beyond conventional skincare products toward the growing “cosmeceutical” sector, where consumers increasingly prioritize skin improvement, functionality, and safety.

As purchasing standards shift from simple brand image to technological reliability, ingredient stability, and manufacturing credibility, companies with medical technology expertise are emerging as new leaders in the beauty industry.

Against this backdrop, Nexvel Biotech has strengthened its competitiveness by establishing an integrated business structure that directly manages research and development (R&D), manufacturing, quality control, exports, and global distribution based on its patented medical device technologies.

Industry experts note that companies capable of independently overseeing the entire process—from product development to global distribution—remain relatively rare in the Korean beauty industry.

Building on its accumulated expertise in the medical aesthetics sector, Nexvel Biotech has expanded its business portfolio by launching Du2LAB, a functional cosmeceutical brand rooted in medical technology.

The brand is being recognized for its differentiated competitiveness, as the company’s skin science-based technologies and quality management systems originally developed for medical devices have been applied to cosmetic product development.

Industry analysts point out that modern consumers increasingly prefer products that deliver visible skin condition improvement and tangible user satisfaction rather than products that simply appear visually appealing.

In particular, the medical cosmeceutical sector—driven by high-performance ingredients, advanced absorption technology, and product safety—is considered one of the fastest-growing segments within the global beauty market.

Reflecting these market trends, Du2LAB plans to present a brand strategy that combines emotional brand experience with medically driven functionality.

The products are reportedly formulated using Nexvel Biotech’s proprietary technologies, focusing on enhanced absorption efficiency, optimized active ingredient delivery, and product safety.

In addition, Nexvel Biotech’s established global distribution network is regarded as another key factor supporting Du2LAB’s growth potential.

Leveraging the international partnerships and export channels built through its medical device and medical aesthetics businesses, the company is expanding into the cosmetics sector while continuously strengthening connections with global buyers through participation in international exhibitions.

Industry observers believe that Du2LAB’s credibility will be further enhanced by the fact that it is backed by a company operating its own manufacturing infrastructure and quality management systems.

In the global beauty market, brands with in-house production capabilities are increasingly gaining competitive advantages as consumers place greater emphasis on quality stability and manufacturing transparency.

A beauty industry expert commented, “The cosmetics industry has entered an era where emotional branding alone is no longer enough to remain competitive.

Companies capable of combining technological expertise, manufacturing reliability, and global distribution competitiveness are expected to lead the market moving forward.

Du2LAB represents a noteworthy example of a brand successfully integrating medical-based functionality with a premium branding strategy.”

A representative from Nexvel Biotech stated, “COSMOBEAUTY SEOUL 2026 will serve as a meaningful opportunity to introduce Du2LAB to domestic consumers and buyers for the first time.

We plan to continue strengthening the brand’s competitiveness through differentiated product development based on medical technology and expanded global market presence.”

Meanwhile, COSMOBEAUTY SEOUL 2026 is recognized as one of Korea’s leading beauty industry exhibitions, attracting domestic and international beauty brands and buyers while serving as a key platform for showcasing the latest K-beauty technologies and global trends.